Vu Thanh Loc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vu Thanh Loc has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Nguyen Manh Cuong
Institute of Chemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam
5 shared publications - Nguyen Xuan Ha
Institute of Chemistry Vietnam Academy of Science and Technology Hanoi Vietnam
4 shared publications - Alexandra Daks
Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia
3 shared publications - Oleg Shuvalov
Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia
3 shared publications - Sergey Parfenyev
Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia
3 shared publications - Tran Thu Huong
Institute of Chemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam
3 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (6) , 814
Discovery of Benzophenanthridine Alkaloids from Zanthoxylum nitidum That Target the MDM2–p53 Axis in NSCLC
Background/Objectives: Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancers and is a leading cause of cancer-related deaths worldwide. Pharmacological targeting of the p53–MDM2 interaction to activate wild-type p53 is a promising strategy for treating NSCLC that retain functional p53 (approximately 50% of all cases). Methods: We screened 33 ethnomedicinal Vietnamese plant extracts for their anticancer effects using p53-expressing and p53-null NSCLC cell models, as well as two non-cancerous cell lines for control. We used an array of different experimental approaches including NMR spectroscopy; molecular docking; an MTT test; cell cycle analysis; apoptosis analysis; wound healing, migration, and invasion assays; Real-Time PCR; immunoblotting; and Seahorse energy profiling to characterize and study the effects of these bioactive compounds on NSCLC cells. Results: Ethanol extract of Zanthoxylum nitidum stems and twigs demonstrated potent and selective activity by inducing p53-dependent cell cycle arrest and apoptosis. Phytochemical analysis identified several benzophenanthridine alkaloids as active constituents. Molecular docking revealed their strong in silico binding to MDM2. Notably, nitidine was the most promising compound among the molecules tested. Unlike nutlin, but similar to SP141 (two well-known MDM2 inhibitors), nitidine strongly stabilized p53 while concomitantly attenuating MDM2 at the protein level. Surprisingly, this effect was p53-independent. Additionally, nitidine suppressed the EMT master regulator Snail, and hence disrupted cellular bioenergetics and inhibited migration and invasion of NSCLC cells. Conclusions: Our findings identify Z. nitidum and nitidine as promising sources for developing novel MDM2-targeting therapeutics against NSCLC irrespective of the p53 status.
- 22 May 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (6) , 814
Open AccessDiscovery of Benzophenanthridine Alkaloids from Zanthoxylum nitidum That Target the MDM2–p53 Axis in NSCLC
Background/Objectives: Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancers and is a leading cause of cancer-related deaths worldwide. Pharmacological targeting of the p53–MDM2 interaction to activate wild-type p53 is a promising strategy for treating NSCLC that retain functional p53 (approximately 50% of all cases). Methods: We screened 33 ethnomedicinal Vietnamese plant extracts for their anticancer effects using p53-expressing and p53-null NSCLC cell models, as well as two non-cancerous cell lines for control. We used an array of different experimental approaches including NMR spectroscopy; molecular docking; an MTT test; cell cycle analysis; apoptosis analysis; wound healing, migration, and invasion assays; Real-Time PCR; immunoblotting; and Seahorse energy profiling to characterize and study the effects of these bioactive compounds on NSCLC cells. Results: Ethanol extract of Zanthoxylum nitidum stems and twigs demonstrated potent and selective activity by inducing p53-dependent cell cycle arrest and apoptosis. Phytochemical analysis identified several benzophenanthridine alkaloids as active constituents. Molecular docking revealed their strong in silico binding to MDM2. Notably, nitidine was the most promising compound among the molecules tested. Unlike nutlin, but similar to SP141 (two well-known MDM2 inhibitors), nitidine strongly stabilized p53 while concomitantly attenuating MDM2 at the protein level. Surprisingly, this effect was p53-independent. Additionally, nitidine suppressed the EMT master regulator Snail, and hence disrupted cellular bioenergetics and inhibited migration and invasion of NSCLC cells. Conclusions: Our findings identify Z. nitidum and nitidine as promising sources for developing novel MDM2-targeting therapeutics against NSCLC irrespective of the p53 status.
- 18 April 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (4) , 159
Chemical Composition, Antimicrobial, and in Silico Molecular Docking Analysis of β-Asarone-Free Essential Oils from Diploid Acorus calamus L. in Mongolia
- 18 April 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (4) , 159
Chemical Composition, Antimicrobial, and in Silico Molecular Docking Analysis of β-Asarone-Free Essential Oils from Diploid Acorus calamus L. in Mongolia
- Open Access
- 28 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1312
The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level
Mushrooms are valued for their nutritional qualities and have been used in traditional medicine since the Neolithic era. They exhibit various bioactivities, including antioxidant, hypocholesterolemic, immunomodulatory, and anticancer effects. The anticancer effects arise via direct action on tumor cells and indirect modulation of the immune system; the latter is the predominant mechanism. Numerous studies indicate that various mushroom species are potent immunostimulants because their cell wall polysaccharides and proteoglycans are recognized by intestinal immune cells. This enhances antitumor immunity through multiple molecular pathways. However, their direct effects on cancer cells are of questionable physiological relevance due to bioavailability constraints. Nevertheless, we hypothesize that the accumulation of non-absorbed polysaccharides in the gastrointestinal tract positions mushrooms as dual-action agents with the potential to treat colorectal cancer by providing indirect immunomodulation and direct local tumor suppression. Conversely, the direct anticancer effects of mushrooms are generally attributed to bioactive secondary metabolites that influence essential cellular processes, including signaling pathways, cell cycle regulation, apoptosis, autophagy, cellular migration, invasion, and cancer stem cell characteristics. Beyond these anticancer effects, clinical evidence suggests that certain mushroom-derived substances can improve survival outcomes for cancer patients and provide supportive care benefits in oncology, thereby improving quality of life. Specifically, mushrooms may mitigate the side effects of chemotherapy and radiotherapy, bolster immune function often suppressed by cancer treatments, and enhance overall well-being. In this review, we discuss the therapeutic benefits of dietary and medicinal mushrooms in cancer care, as well as unresolved challenges and future research directions.
- 28 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1312
Open AccessThe Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level
Mushrooms are valued for their nutritional qualities and have been used in traditional medicine since the Neolithic era. They exhibit various bioactivities, including antioxidant, hypocholesterolemic, immunomodulatory, and anticancer effects. The anticancer effects arise via direct action on tumor cells and indirect modulation of the immune system; the latter is the predominant mechanism. Numerous studies indicate that various mushroom species are potent immunostimulants because their cell wall polysaccharides and proteoglycans are recognized by intestinal immune cells. This enhances antitumor immunity through multiple molecular pathways. However, their direct effects on cancer cells are of questionable physiological relevance due to bioavailability constraints. Nevertheless, we hypothesize that the accumulation of non-absorbed polysaccharides in the gastrointestinal tract positions mushrooms as dual-action agents with the potential to treat colorectal cancer by providing indirect immunomodulation and direct local tumor suppression. Conversely, the direct anticancer effects of mushrooms are generally attributed to bioactive secondary metabolites that influence essential cellular processes, including signaling pathways, cell cycle regulation, apoptosis, autophagy, cellular migration, invasion, and cancer stem cell characteristics. Beyond these anticancer effects, clinical evidence suggests that certain mushroom-derived substances can improve survival outcomes for cancer patients and provide supportive care benefits in oncology, thereby improving quality of life. Specifically, mushrooms may mitigate the side effects of chemotherapy and radiotherapy, bolster immune function often suppressed by cancer treatments, and enhance overall well-being. In this review, we discuss the therapeutic benefits of dietary and medicinal mushrooms in cancer care, as well as unresolved challenges and future research directions.
- 31 October 2025
- Published by Thai Nguyen University in TNU Journal of Science and Technology
- Vol. 231 (01) , 144-150
MORINDONE FROM MORINDA LONGISSIMA INHIBITS CYTOKINE PRODUCTION IN TLR-COSTIMULATED MACROPHAGE MODEL POTENTIALLY THROUGH JNK/NF-κB/STAT1
Morindone là một hợp chấtanthraquinoneđược phân lập từ thân rễ cây Nhó đông (Morinda longissima Y.Z Ruan,họ Rubiaceae) và đã được biết có nhiều hoạt tính sinh học. Mục đích của nghiên cứu này là tìm hiểu các hoạt tính mới của morindone tách từ cây Morinda longissima lên sự sản xuất các cytokine viêm ở đại thực bào đồng kích thích bởi LPS và poly (I:C), là mô hình đồng nhiễm vi khuẩn và virus. Tế bào RAW264.7 được xử lý trước 30 phút với 3, 10, 30, hoặc 60 μM sau đó được kích thích bởi LPS (1 µg/mL) và poly (I:C) (20 µg/mL). Các tế bào được thu sau 3, 6, 24 giờ cho qRT-PCR và dịch tế bào được thu sau 24h cho ELISA. Lần đầu tiên chứng minh được morindonecó khả năng ức chế sản sinh các cytokine viêm IL-6, TNF-α, và IL-10 theo kiểu phụ thuộc nồng độ trên tế bào RAW 264.7 bị đồngkích thích nhiễm vi khuẩn và virus bằngLPS và poly (I:C), với giá trị IC50 tương ứng là 3,2 ± 1,2 μM với IL-6, 2,2 ± 1,0μM với TNF-αvà 9,1 ± 3,4 μM với IL-10. Hơn nữa, morindone ở nồng độ 3, 10, 30, hay 60 μM ức chếbiểu hiện của các gen điều khiển sinh cytokine tương ứng với Jnk 17%, 26%, 53%, và 64%,Nf-κb1 21%, 53%, 61%, và 66%, và Stat1 22%, 26%, 57%, và 62%. Những kết quả này chứng minh morindone là một hợp chất triển vọng cho việc điều trị các bệnh nhiễm trùng đồng thời vi khuẩn và virus.
- 31 October 2025
- Published by Thai Nguyen University in TNU Journal of Science and Technology
- Vol. 231 (01) , 144-150
MORINDONE FROM MORINDA LONGISSIMA INHIBITS CYTOKINE PRODUCTION IN TLR-COSTIMULATED MACROPHAGE MODEL POTENTIALLY THROUGH JNK/NF-κB/STAT1
Morindone là một hợp chấtanthraquinoneđược phân lập từ thân rễ cây Nhó đông (Morinda longissima Y.Z Ruan,họ Rubiaceae) và đã được biết có nhiều hoạt tính sinh học. Mục đích của nghiên cứu này là tìm hiểu các hoạt tính mới của morindone tách từ cây Morinda longissima lên sự sản xuất các cytokine viêm ở đại thực bào đồng kích thích bởi LPS và poly (I:C), là mô hình đồng nhiễm vi khuẩn và virus. Tế bào RAW264.7 được xử lý trước 30 phút với 3, 10, 30, hoặc 60 μM sau đó được kích thích bởi LPS (1 µg/mL) và poly (I:C) (20 µg/mL). Các tế bào được thu sau 3, 6, 24 giờ cho qRT-PCR và dịch tế bào được thu sau 24h cho ELISA. Lần đầu tiên chứng minh được morindonecó khả năng ức chế sản sinh các cytokine viêm IL-6, TNF-α, và IL-10 theo kiểu phụ thuộc nồng độ trên tế bào RAW 264.7 bị đồngkích thích nhiễm vi khuẩn và virus bằngLPS và poly (I:C), với giá trị IC50 tương ứng là 3,2 ± 1,2 μM với IL-6, 2,2 ± 1,0μM với TNF-αvà 9,1 ± 3,4 μM với IL-10. Hơn nữa, morindone ở nồng độ 3, 10, 30, hay 60 μM ức chếbiểu hiện của các gen điều khiển sinh cytokine tương ứng với Jnk 17%, 26%, 53%, và 64%,Nf-κb1 21%, 53%, 61%, và 66%, và Stat1 22%, 26%, 57%, và 62%. Những kết quả này chứng minh morindone là một hợp chất triển vọng cho việc điều trị các bệnh nhiễm trùng đồng thời vi khuẩn và virus.
- 22 May 2025
- Published by Taylor & Francis in Natural Product Research
- p. 1-8
Therapeutic effects of Chrysanthemum zawadzkii and its active compound eupatilin in rheumatoid arthritis: in silico and in vitro validation
The 50% ethanol extract of the aerial parts of Chrysanthemum zawadzkii (CZ extract) was evaluated for its inhibitory effects on the production of NO, TNF-α, and XO, and seven isolated flavonoids were tested for COX-2 inhibitory activity. The ethanol extract of C. zawadzkii exhibited a strong inhibitory effect on NO and XO overproduction, with IC50 values of 6.91 µg/mL and 83.48 µg/mL, respectively. Eupatilin (3) significantly suppressed COX-2 expression at a concentration of 100 µM (p < 0.05). Molecular docking analysis and ADMET predictions revealed that eupatilin forms hydrogen bonds and π-σ interactions, which significantly contribute to its binding affinity with residues in the enzyme's active site. Additionally, it exhibits low oral toxicity and good bioavailability in humans. These findings demonstrate the potential of CZ extract and its active compound, eupatilin, as naturally occurring agents with anti-heumatoid arthritis activities, capable of potently inhibiting COX-2 signalling in vitro.
- 22 May 2025
- Published by Taylor & Francis in Natural Product Research
- p. 1-8
Therapeutic effects of Chrysanthemum zawadzkii and its active compound eupatilin in rheumatoid arthritis: in silico and in vitro validation
The 50% ethanol extract of the aerial parts of Chrysanthemum zawadzkii (CZ extract) was evaluated for its inhibitory effects on the production of NO, TNF-α, and XO, and seven isolated flavonoids were tested for COX-2 inhibitory activity. The ethanol extract of C. zawadzkii exhibited a strong inhibitory effect on NO and XO overproduction, with IC50 values of 6.91 µg/mL and 83.48 µg/mL, respectively. Eupatilin (3) significantly suppressed COX-2 expression at a concentration of 100 µM (p < 0.05). Molecular docking analysis and ADMET predictions revealed that eupatilin forms hydrogen bonds and π-σ interactions, which significantly contribute to its binding affinity with residues in the enzyme's active site. Additionally, it exhibits low oral toxicity and good bioavailability in humans. These findings demonstrate the potential of CZ extract and its active compound, eupatilin, as naturally occurring agents with anti-heumatoid arthritis activities, capable of potently inhibiting COX-2 signalling in vitro.
- 12 December 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 743, 151169
MDM2 up-regulates the energy metabolism in NSCLC in a p53-independent manner
- 12 December 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 743, 151169
MDM2 up-regulates the energy metabolism in NSCLC in a p53-independent manner
- Open Access
- 26 June 2024
- Published by Publishing House for Science and Technology, Vietnam Academy of Science and Technology (Publications) in Vietnam Journal of Science and Technology
IN VITRO AND IN SILICO INHIBITORY ACTIVITY OF ANGIOTENSIN-CONVERTING ENZYME II AND ANTI-INFLAMMATORY EFFECTS OF NATURAL COMPOUNDS FROM RHEUM OFFICINALE ROOTS
Rhubarb roots (Rheum officinale), a common medicinal plant in folk remedies, and their chemical compositions were investigated for their inhibitory activity of angiotensin-converting enzyme II and anti-inflammatory effects by inhibiting NO production and IL-6 expression. Four natural compounds, including two anthraquinones, chrysophanol (2) and emodin (3), and two stilbenes, rhapontigenin (1) and trans-piceatannol (4), were isolated from the roots of Rhubarb. The results showed that rhapontigenin (1) exhibited an inhibitory effect on the ACE-2 enzyme with an IC50 value of 132 mM. In an in silico study, rhapotigenin (1) had a binding energy value of -9.32 kcal/mol, lower than MLN-4760, on ACE-2. Both rhapontigenin (1) and emodin (3) exhibited inhibitory activity on NO production in primary cultures of macrophages RAW264.7, with IC50 values ranging from 5.65 to 32.3 µg/mL. This is the first study of the anti-ACE-2 and anti-inflammatory activity of Rhubarb root extract and its constituents.
- 26 June 2024
- Published by Publishing House for Science and Technology, Vietnam Academy of Science and Technology (Publications) in Vietnam Journal of Science and Technology
Open AccessIN VITRO AND IN SILICO INHIBITORY ACTIVITY OF ANGIOTENSIN-CONVERTING ENZYME II AND ANTI-INFLAMMATORY EFFECTS OF NATURAL COMPOUNDS FROM RHEUM OFFICINALE ROOTS
Rhubarb roots (Rheum officinale), a common medicinal plant in folk remedies, and their chemical compositions were investigated for their inhibitory activity of angiotensin-converting enzyme II and anti-inflammatory effects by inhibiting NO production and IL-6 expression. Four natural compounds, including two anthraquinones, chrysophanol (2) and emodin (3), and two stilbenes, rhapontigenin (1) and trans-piceatannol (4), were isolated from the roots of Rhubarb. The results showed that rhapontigenin (1) exhibited an inhibitory effect on the ACE-2 enzyme with an IC50 value of 132 mM. In an in silico study, rhapotigenin (1) had a binding energy value of -9.32 kcal/mol, lower than MLN-4760, on ACE-2. Both rhapontigenin (1) and emodin (3) exhibited inhibitory activity on NO production in primary cultures of macrophages RAW264.7, with IC50 values ranging from 5.65 to 32.3 µg/mL. This is the first study of the anti-ACE-2 and anti-inflammatory activity of Rhubarb root extract and its constituents.